Mary Elizabeth Klein

Mary Elizabeth (Beth) Klein has a diverse work experience in the healthcare industry. Mary Elizabeth(Beth) started their career in General Electric Healthcare in 1998 as the Global General Manager for Nuclear Medicine and PET/CT business. Mary Elizabeth(Beth) successfully launched the Discovery LS PET/CT, establishing GE as a global leader in the PET market.

In 2000, Klein became the President and CEO of Americas Sales at GE Healthcare, where they served until 2002. Mary Elizabeth(Beth) then joined TomoTherapy in 2006 as the Executive Vice President of Global Sales, contributing to the company's sales growth until 2008.

From 2009 to 2015, Klein held various roles at IBA, a proton therapy company. Mary Elizabeth(Beth) started as the Global Sales Director from 2009 to 2013. During this time, they played a key role in the sales and marketing activities for the US and Canada. Klein then became the Executive Vice President of Proton Therapy Sales for North America from 2013 to 2015, responsible for equipment sales and leading the team in the US and Canada. In 2016, they became the President of IBA Proton Therapy North America.

Overall, Klein's work experience demonstrates their expertise in sales and leadership roles in the healthcare industry, specifically in nuclear medicine, PET/CT, and proton therapy technologies.

Mary Elizabeth (Beth) Klein obtained a Bachelor of Science in Biology and Bachelor of Arts in Languages from the University of Notre Dame from 1974 to 1979. From 1987 to 1989, they pursued a Master of Business Administration in Business Administration and Management, General at the D'Amore-McKim School of Business at Northeastern University.